{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:09:14Z","timestamp":1792789754980,"version":"4.5.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T00:00:00Z","timestamp":1451433600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0144856","type":"journal-article","created":{"date-parts":[[2015,12,30]],"date-time":"2015-12-30T13:46:00Z","timestamp":1451483160000},"page":"e0144856","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":170,"title":["Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis"],"prefix":"10.1371","volume":"10","author":[{"given":"A. T.","family":"Cohen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. A.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Phatak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tushabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Batson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,12,30]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinte.160.6.761","article-title":"Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study","volume":"160","author":"JA Heit","year":"2000","journal-title":"Archives of Internal Medicine"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3324\/haematol.10516","article-title":"The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients","volume":"92","author":"P Prandoni","year":"2007","journal-title":"Haematologica"},{"issue":"14","key":"ref3","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","article-title":"Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: the Vienna prediction model","volume":"121","author":"S Eichinger","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"ref4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/ATVBAHA.108.182428","article-title":"Venous thromboembolism: risk factors for recurrence","volume":"29","author":"T Zhu","year":"2009","journal-title":"Arteriosclerosis, Thrombosis, and Vascular Biology"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3111\/13696998.2010.546465","article-title":"Economic burden of venous thromboembolism: a systematic review","volume":"14","author":"A Ruppert","year":"2011","journal-title":"Journal of Medical Economics"},{"issue":"8","key":"ref6","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1592\/phco.29.8.943","article-title":"Economic burden of venous thromboembolism in hospitalized patients","volume":"29","author":"PP Dobesh","year":"2009","journal-title":"Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1365-2141.2009.07601.x","article-title":"Post-thrombotic syndrome: prevalence, prognostication and need for progress","volume":"145","author":"P Prandoni","year":"2009","journal-title":"Br J Haematol"},{"issue":"22","key":"ref8","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1056\/NEJMp048088","article-title":"Chronic thromboembolic pulmonary hypertension\u2014not so rare after all","volume":"350","author":"IM Lang","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"ref9","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.amjmed.2013.02.024","article-title":"Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort","volume":"126","author":"V Tagalakis","year":"2013","journal-title":"The American Journal of Medicine"},{"issue":"4","key":"ref10","first-page":"756","article-title":"Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality","volume":"98","author":"AT Cohen","year":"2007","journal-title":"Thrombosis and Haemostasis"},{"issue":"22","key":"ref11","first-page":"401","article-title":"Venous thromboembolism in adult hospitalizations\u2014United States, 2007\u20132009","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1","key":"ref12","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1477-9560-10-24","article-title":"Treatment of venous thromboembolism\u2014effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management","volume":"10","author":"B Hass","year":"2012","journal-title":"Thrombosis Journal"},{"key":"ref13","unstructured":"National Institute for Health and Care Excellence. CG92: Venous thromboembolism\u2014reducing the risk. 2010. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/guidance.nice.org.uk\/CG92\" xlink:type=\"simple\">http:\/\/guidance.nice.org.uk\/CG92<\/ext-link> Accessed May 2014."},{"issue":"2","key":"ref14","doi-asserted-by":"crossref","first-page":"7S","DOI":"10.1378\/chest.1412S3","article-title":"Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"GH Guyatt","year":"2012","journal-title":"Chest"},{"issue":"17","key":"ref15","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1200\/JCO.2013.49.1118","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"GH Lyman","year":"2013","journal-title":"Journal of Clinical Oncology"},{"issue":"2","key":"ref16","doi-asserted-by":"crossref","first-page":"e44S","DOI":"10.1378\/chest.11-2292","article-title":"Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"W Ageno","year":"2012","journal-title":"Chest"},{"issue":"2","key":"ref17","first-page":"101","article-title":"Prevention and treatment of venous thromboembolism. International Consensus Statement (guidelines according to scientific evidence)","volume":"25","author":"A Nicolaides","year":"2006","journal-title":"International Angiology"},{"issue":"Suppl 1","key":"ref18","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1002\/ajh.23139","article-title":"New oral anticoagulants: a view from the laboratory","volume":"87","author":"JI Weitz","year":"2012","journal-title":"American Journal of Hematology"},{"issue":"26","key":"ref19","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"R Bauersachs","year":"2010","journal-title":"The New England Journal of Medicine"},{"issue":"14","key":"ref20","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"HR Buller","year":"2012","journal-title":"The New England Journal of Medicine"},{"issue":"9","key":"ref21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"G Agnelli","year":"2013","journal-title":"The New England Journal of Medicine"},{"issue":"7","key":"ref22","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"S Schulman","year":"2014","journal-title":"Circulation"},{"issue":"15","key":"ref23","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"HR Buller","year":"2013","journal-title":"The New England Journal of Medicine"},{"issue":"24","key":"ref24","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"S Schulman","year":"2009","journal-title":"The New England Journal of Medicine"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"e419S","DOI":"10.1378\/chest.11-2301","article-title":"Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"C Kearon","year":"2012","journal-title":"Chest"},{"key":"ref26","unstructured":"National Institute for Health and Care Excellence. The guidelines manual. London: National Institute for Health and Care Excellence; 2009. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.nice.org.uk\/guidelinesmanual\" xlink:type=\"simple\">http:\/\/www.nice.org.uk\/guidelinesmanual<\/ext-link> Accessed May 2014."},{"key":"ref27","unstructured":"Dias S, Welton, N.J., Sutton, A.J. &amp; Ades, A.E. NICE DSU Technical Support Document 2: A Generalised Linear Modelling Framework for Pairwise and Network Meta-Analysis of Randomised Controlled Trials. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.nicedsuorg.uk\/\" xlink:type=\"simple\">www.nicedsuorg.uk<\/ext-link>. 2011."},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-9560-11-21","article-title":"Oral rivaroxaban versus standard therapy for the treatment of symptomatic venous thromboembolism: a pooled analysis of the EINSTEIN-DVT and PE randomized studies","volume":"11","author":"MH Prins","year":"2013","journal-title":"Thrombosis Journal"},{"key":"ref29","article-title":"Recurrent Venous Thromboembolism: What Is the Risk and How to Prevent It","author":"G Palareti","year":"2012","journal-title":"Scientifica"},{"issue":"4","key":"ref30","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"S Schulman","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"ref31","article-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]","author":"JPT Higgins","year":"2011"},{"issue":"1","key":"ref32","first-page":"452","article-title":"The epidemiology of venous thromboembolism in the community","volume":"86","author":"JA Heit","year":"2001","journal-title":"Thrombosis and Haemostasis"},{"issue":"8","key":"ref33","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1538-7836.2005.01415.x","article-title":"Venous thromboembolism: disease burden, outcomes and risk factors","volume":"3","author":"JA Heit","year":"2005","journal-title":"Journal of Thrombosis and Haemostasis: JTH"},{"issue":"43","key":"ref34","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1093\/eurheartj\/ehu283","article-title":"2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism","volume":"35","author":"SV Konstantinides","year":"2014","journal-title":"European Heart Journal"},{"issue":"11","key":"ref35","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1111\/j.1538-7836.2011.04507.x","article-title":"External and internal validity of open label or double-blind trials in oral anticoagulation: better, worse or just different?","volume":"9","author":"J Beyer-Westendorf","year":"2011","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e7498","DOI":"10.1136\/bmj.e7498","article-title":"Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials","volume":"345","author":"BD Fox","year":"2012","journal-title":"BMJ"},{"issue":"6","key":"ref37","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.thromres.2014.03.035","article-title":"Indirect treatment comparison of new oral anticoagulants for the treatment of acute venous thromboembolism","volume":"133","author":"N Kang","year":"2014","journal-title":"Thrombosis Research"},{"issue":"3","key":"ref38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jth.12485","article-title":"Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis","volume":"12","author":"T van der Hulle","year":"2014","journal-title":"Journal of Thrombosis and Haemostasis: JTH"},{"issue":"8","key":"ref39","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1111\/j.1538-7836.2008.03054.x","article-title":"Efficacy and safety of the oral direct factor Xa inhibitor apixaban for symptomatic deep vein thrombosis. The Botticelli DVT dose-ranging study","volume":"6","author":"H Buller","year":"2008","journal-title":"Journal of Thrombosis and Haemostasis"},{"issue":"11","key":"ref40","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jama.2014.10538","article-title":"Clinical and safety outcomes associated with treatment of acute venous thromboembolism: a systematic review and meta-analysis","volume":"312","author":"LA Castellucci","year":"2014","journal-title":"JAMA"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11239-014-1102-5","article-title":"Indirect comparison of dabigatran, rivaroxaban, apixaban and edoxaban for the treatment of acute venous thromboembolism","volume":"39","author":"S Mantha","year":"2015","journal-title":"Journal of Thrombosis and Thrombolysis"},{"issue":"5","key":"ref42","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1160\/TH08-06-0352","article-title":"Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study","volume":"101","author":"FA Spencer","year":"2009","journal-title":"Thrombosis and Haemostasis"},{"issue":"5","key":"ref43","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1160\/TH08-06-0390","article-title":"Clinical outcome of patients with major bleeding after venous thromboembolism. Findings from the RIETE Registry","volume":"100","author":"JA Nieto","year":"2008","journal-title":"Thrombosis and Haemostasis"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1111\/j.1538-7836.2010.04039.x","article-title":"Major bleeding as a predictor of mortality in patients with venous thromboembolism: findings from the RIETE Registry","volume":"8","author":"P Prandoni","year":"2010","journal-title":"Journal of thrombosis and haemostasis"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0144856","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T22:38:20Z","timestamp":1567463900000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0144856"}},"subtitle":[],"editor":[{"given":"Hugo","family":"ten Cate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,12,30]]},"references-count":44,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2015,12,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0144856","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,30]]}}}